Validated reverse phase HPLC method for simultaneous estimation of atorvastatin and atenolol in tablets

Der Pharmacia Lettre

Volumn 3, Issue 4, 2011, Pages 393-403

  Gupta, Krishna R ^a   Wadodkar, Akshay R ^a   Wadodkar, Sudhir G ^a  

^a India   (India)

Author keywords

Atenolol; Atorvastatin; Hplc; Stability studies; Tablets

Indexed keywords

ACETONITRILE; ATENOLOL; ATORVASTATIN; PHOSPHATE BUFFERED SALINE; PHOSPHORIC ACID;

ACIDITY; ALKALINITY; ARTICLE; CALIBRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG HYDROLYSIS; DRUG MIXTURE; DRUG STABILITY; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMIDITY; PHOTOLYSIS; PHYSICAL PHASE; PROCESS DEVELOPMENT; REACTION TIME; TABLET FORMULATION; VALIDATION PROCESS;

EID: 80052862426     PISSN: None     EISSN: 09755071     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. n., Published by Merck Research Lab, Division of Merck & Co, White House Station, NJ, USA, 2001, 148.
2. Indian Pharmacopoeia 1996 Vol 1. Govt. of India Ministry of Health and Family Welfare, Controller of Publication, New Delhi, p. 74.
3. M. Jenal, Z. Duyang, B.C. Chen and Teitz D. Rapid Commun Mass Spectrom, 1999, 13, 1003-15.
4. Hermann M., Christensen H., J.L. Reubsaet, Anal Bioanal Chem., 2005, 382, 1242-9.
5. S. R. Dhaneshwar, A. Mhaske and S.S. Kadam, Ind. J. Pharm. Sci., 2005, 67,182-186.
6. B.B. Hoffman, in: J. G. Hardman, L. E. Limbird, A. G. Gilman (eds), Goodman & Goodman¥s The Pharmacological Basis of Therapeutics, tenth ed., MacGraw-Hill, Rio de Janeiro, 10, 1987, p. 1011-1021.
7. United States Pharmacopoeia 26,The National Formulary USP 26-NF1, Rockville, MD, 2003
8. British Pharmacopoeia London Her Majesty's Stationary Office, Vol 2, 2001
9. A. Gulcu, C. Yucesoy, and S. Serin, Farmaco, 2004, 59, 487.
10. S. M. Al-Ghannam and F. Belal, J. AOAC Int., 2002, 85, 817.
11. A. S. Amin, G. H. Ragab, and H. Saleh, J. Pharm. Biomed. Anal., 2002, 30,1347
12. S. M. Al-Ghannam, J. Pharm. Biomed. Anal., 2006, 40,151.
13. M. C. F. Ferraro, P. M. Castellano, and T. S. Kaufman, J. Pharm. Biomed. Anal., 2004, 34, 305.
14. I. R. Martinez, M. C. G. A. Coque, and R. M. V. Camanas, J. Chromatogr., A: 1997, 765 221.
15. A. P. Argekar, and J. G. Sawant, J. Liq. Chromatogr. Rel. Technol., 1999, 22: 1571.
16. A. P. Argekar, and S.G. Powar, Farmaco, 2000, 21,1137.
17. D. P. Nikolelis, S. E. Petropoulou, and M. V. Mitrokotsa, Bioelectrochemistry, 2002, 58, 107.
18. S. S. M. Hassan, M. M. Abou-Sekkina, M. A. El-Ries, and A. A. Wassel, J. Pharm. Biomed. Anal., 2003, 32,175.
19. M. Shamsipur, and F. Jalali, Anal. Lett., 2005, 38, 401.
20. P. S. Bonato and A. C. C. Briguenti, Drug Dev. Ind. Pharm., 2005, 31:209.
21. A. Shafaati and B. J. Clark, Anal. Lett. 1996,141, 547.
22. M. I. Maguregui, R. M. Jimenez, and R. M. Alonso, J. Chromatogr. Sci., 1998, 36, 516.
23. R. N. Goyal, V. K. Gupta, M. Oyama, N. Bachheti, Electrochem. Commun, 2006, 8, 65.
24. Goyal R N and. Singh S P, Talanta, 2006, 39, 932.
25. International Conference on Harmonization, Draft Guideline on Validation of Analytical Procedure, Definations and Terminology, Federal Register, 1995, 11260-11262